리더십

당사의 다양한 경험, 비즈니스 인사이트 및 공동의 목표의식은 직원들이 잠재력을 최대한 발휘하도록 독려하기 위한 당사의 일상적인 결정에 추진력을 부여합니다.

Mary Duseau - President Molecular Devices

Mary Duseau

사장

Mary는 생명 과학 시장에서 영업, 마케팅 및 사업 관리 분야에서 점점 더 많은 직무를 맡으면서 25년 이상의 경력을 보유하며 Molecular Devices에 합류했습니다.

Molecular Devices에 합류하기 전에는 Danaher 계열사인 Leica Biosystems에서 상업 관리 부문 수석 부사장을 역임했습니다. Danaher에 합류하기 전에 Mary는 Roka Bioscience의 CEO 겸 사장을 역임했으며 그 전에는 Andor Technologies의 영업 담당 수석 부사장, PerkinElmer의 영업 및 마케팅 담당 글로벌 부사장을 역임했습니다. 또한 PerkinElmer에서 그녀는 신약 발굴 및 개발 시장에 초점을 맞춘 Imaging 및 측정 사업부의 리더 역할을 맡았습니다.

그녀는 매사추세츠 대학에서 생화학 학사 학위를 취득했습니다.

Hema Sundarraj, Chief Financial Officer at Molecular Devices

Hema Sundarraj

Chief Financial Officer

Hema Sundarraj serves as Chief Financial Officer of Molecular Devices, where she leads the global Finance organization to support strategic execution, accelerate growth, and strengthen financial and operational performance.

Most recently, she was Chief Financial Officer at Phenomenex, a Danaher operating company within the Life Sciences platform. In this role, she drove strong financial results and supported growth initiatives by enhancing working capital management, leading strategic investments, and advancing the company’s IT and eCommerce capabilities. She is also known for building high-performing, engaged teams.

Previously, Hema held senior finance leadership roles at Cepheid, Applied Materials, Nanometrics, Mattson Technology, and Sunpreme. Her experience spans public and private companies, as well as growth-stage organizations.

Hema holds an MBA in Finance and Marketing from XLRI Jamshedpur and is an inactive CPA in the state of California.

Lars Hartvig Kristiansen-Vice President, Product Innovation & Strategy at Molecular Devices

Lars Hartvig Kristiansen

Vice President, Product Innovation & Strategy

Lars Hartvig Kristiansen is Vice President of Product Innovation & Strategy, responsible for leading strategic initiatives, driving innovation, and overseeing the global product management team. He leads cross-functional efforts to grow the business through M&A, licensing, and partnerships, while guiding strategic planning and execution across the company.

Lars brings over a decade of experience in life sciences and management consulting. At Agilent Technologies, he held senior roles across strategy, operations, and M&A, including leading strategic growth initiatives for the $4B Life Sciences group and most recently serving as General Manager, running the Global Automation Solutions P&L. He holds Bachelor’s and Master’s degrees in Engineering from Aalborg University, with a focus on Technology Management and Supply Chain.

Dan Green - Vice President of Research and Development at Molecular Devices

Dan Green

연구개발 부사장

Dan은 2020년 6월에 R&D 부사장으로 임명되었습니다. 이전에 2018년 9월부터 BioImaging R&D의 선임 이사를, 2015년 4월부터는 소프트웨어의 선임 이사를 역임했습니다. 소프트웨어 개발자로 Universal Imaging Corporation에 입사한 뒤, 1988년부터 Molecular Devices와 그 피합병회사에서 근무했습니다. 그 이후로, 점차 더 큰 책임이 필요한 다양한 기술 및 리더 직무를 수행해 왔습니다. Dan은 일리노이 대학교 어바나 샴페인 캠퍼스에서 컴퓨터과학 석사를, 뉴욕 주의 이타카에 소재한 코넬 대학교에서 학사 학위를 받았습니다.
Krishnapal Solanki - Vice President, DBS at Molecular Devices

Krishnapal Solanki

부사장, DBS

Krishnapal은 DBS 부사장으로서 전 세계적으로 모든 기능의 지속적인 개선 노력을 감독합니다. Krishnapal은 2021년 11월년에 Molecular Devices에 합류하여 서로 다른 3개사의 Danaher 운영 회사에서 다양한 기능 개발을 주도한 13년간의 경험을 쌓았습니다.

Krishnapal의 Danaher에서의 여정은 고객(생명과학 연구)으로 시작하여 이후 Leica Microsystems의 수석 현장 서비스 엔지니어로서 Danaher 직원으로 전환을 꾀했으며, 현장 서비스 운영의 지역 감독자, 성장 관리자 등 다양한 발전적인 역할을 수행했습니다. 미국에서는 Cepheid의 영업 및 마케팅 수석 관리자였으며, 가장 최근에는 Molecular Devices의 DBS 혁신 이사로 재직했습니다. Krishnapal은 DM/VM, Funnel Management 및 PSP와 같은 Danaher 프로세스 개선 도구에 능숙하며 이에 대한 인증을 받았으며 다양한 Danaher Opcos의 교차 기능 팀을 위한 Kaizen 워크숍을 추진하고 이끌었습니다. 그의 업무 전문 지식에는 모든 3개의 DBS 엔진(상용, 혁신 및 서비스) 설치 및 유지 관리가 포함되어 전체 조직 성장을 주도합니다. Krishnapal은 DE&I 활동에도 참여하고 있으며 2021년부터 2022년까지 Danaher의 Asian Descent + Friends ARG에서 회원 참여 리더로 활동했습니다.

Krishnapal은 UT Arlington과 SW Medical Center Dallas에서 의생명공학 석사 학위를 취득했습니다. 그는 인도에서 의생명공학 학사 학위를 취득했습니다.

Lakshmi Sailaja Eleswarapu -Vice President, IT at Molecular Devices

Lakshmi Sailaja Eleswarapu

Vice President, IT

As Vice President of IT for SCIEX, Molecular Devices, and Danaher Life Sciences, Lakshmi Eleswarapu champions global IT strategy, fostering technological innovation and organizational excellence. Her role extends to supporting the Danaher Life Sciences Innovation Group (LSIG) commercial team and contributing to the L1 team at Molecular Devices. Her tenure includes significant achievements in business transformation, M&A IT integrations, and diversity initiatives. Lakshmi's career spans 26 years in IT, with the last 16 years dedicated to Danaher, positioning her to drive future innovation and growth.

Lakshmi holds a Bachelor’s in Mathematics with Honors from SSSIHL University (India) and a Master’s in Computer Applications from Osmania University (India).

Ray Li, Vice President of Global Operations, Molecular Devices

Ray Li

Vice President of Global Operations

Ray Li, Vice President of Global Operations, brings nearly 18 years of invaluable experience to Molecular Devices. Since joining in 2007 as a Manufacturing Engineer, Ray has held key roles including Production Manager, Production Manager & DBSL, Operations Manager, and Shanghai Plant General Manager, with Salzburg added to his responsibilities in 2022. In his new role, Ray will drive progress by enhancing operational efficiency and fostering innovation across global operations. Based in Shanghai, his extensive background and strategic vision make him a vital asset to our leadership team.
Tracy Clarke, Vice President of Service at Molecular Devices

Tracy Clarke

Vice President of Service

Tracy Clarke, Vice President of Service, brings over 30 years of experience in the laboratory and medical industry to Molecular Devices. With a remarkable 17-year tenure at Leica Biosystems, Tracy excels in building high-performing teams, managing complex projects, and driving continuous improvement. As Senior Director of Service at Leica, she led a team of 210 professionals, managed a $96M P&L, and consistently drove customer satisfaction and revenue growth. Tracy is committed to enhancing our customers’ experience, building service capabilities, fostering strong cross-functional relationships, and promoting an inclusive culture.

Tracy Clarke, holds a master’s degree in Veterinary Medical Science and a Bachelor’s degree in Molecular Biology & Cell Science from the University of Florida.

Yang Shi- Vice President, Global Commercial at Molecular Devices

Yang Shi

Vice President, Global Commercial

Yang Shi, Ph.D., MBA, is Vice President of Global Commercial at Molecular Devices, where he leads a worldwide team spanning Sales, Field Applications, Customer Service, and Sales Operations. He brings extensive commercial leadership experience from across Danaher, including roles at SCIEX, Phenomenex, and Integrated DNA Technologies (IDT).

Most recently, he served as Vice President of Americas Sales at IDT and previously as Vice President of Global Sales at Phenomenex. Earlier in his career, Yang advanced scientific innovation as a Senior Scientist with Waters Corporation, Thermo Fisher Scientific, and the Sanford Burnham Institute.

Yang holds a Ph.D. in Chemical Engineering from Yale University, an MBA from the University of Massachusetts–Amherst, and B.S. and M.S. degrees in Biochemical Engineering from Tianjin University.